Myomo to Report Fourth Quarter and Full Year 2021 Financial Results on March 9, 2022 Read More > March 2, 2022
Myomo Strengthens Intellectual Property Portfolio with Receipt of Key Patent in Japan Read More > February 17, 2022
Independent Research with Myomo’s MyoPro® Shows Clinically Significant Gains in Motor Function in Individuals with Chronic Moderate-to-Severe Arm Weakness Read More > February 14, 2022
Myomo Amends China Joint Venture Agreement, Executes Technology and Trademark License Agreement Read More > January 5, 2022
Myomo to Report Third Quarter 2021 Financial Results on November 10, 2021 Read More > November 3, 2021
